![]() |
|
|
Vol. 25, Issue 11, 1234-1241, 1997
Department of Biochemistry and Center in Molecular Toxicology, Vanderbilt University School of Medicine (F.P.G., A.P.), Department of Molecular and Experimental Medicine NX-4, The Scripps Research Institute (E.F.J., T.H.R., C.v.W., J.C., F.J.), Department of Pharmacology, University of California San Diego Cancer Center (C.P.S., R.H.T.), Department of Gastroenterology and Hepatology, Medizinische Hochschule Hannover (M.P.M.), URA CNRS 1288 Physiopathologie et Pharmacologie Articulaires, Faculté de Medicine, BP184-5405 Vandoevre lés Nancy (S.F-G.), and Biomedical Research Centre (M.P.) and Department of Molecular and Cellular Pathology, Ninewells Medical School, The University Dundee (B.B.)
This article is a report on a symposium held at the March 1997 meeting of the American Society for Pharmacology and Experimental Therapeutics in San Diego. Current developments in the heterologous expression of cytochrome P450, NADPH-cytochrome P450 reductase, glutathione transferase, and UDP-glucuronosyltransferase enzymes are described. Systems include bacteria, insect cells, and transient and stable mammalian cells. Uses of the products are described for discernment of which enzymes are involved in metabolism of drugs, genotoxicity assays, mutagenesis (for structure-activity relationships), large scale production of enzyme products, antibody production, and production of proteins for biophysical studies.
This article has been cited by other articles:
![]() |
M. Kurkela, J. A. Garcia-Horsman, L. Luukkanen, S. Morsky, J. Taskinen, M. Baumann, R. Kostiainen, J. Hirvonen, and M. Finel Expression and Characterization of Recombinant Human UDP-glucuronosyltransferases (UGTs). UGT1A9 IS MORE RESISTANT TO DETERGENT INHIBITION THAN THE OTHER UGTs AND WAS PURIFIED AS AN ACTIVE DIMERIC ENZYME J. Biol. Chem., January 31, 2003; 278(6): 3536 - 3544. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shimada, Y. Oda, E. M. J. Gillam, F. P. Guengerich, and K. Inoue Metabolic Activation of Polycyclic Aromatic Hydrocarbons and Other Procarcinogens by Cytochromes P450 1A1 and P450 1B1 Allelic Variants and Other Human Cytochromes P450 in Salmonella typhimurium NM2009 Drug Metab. Dispos., September 1, 2001; 29(9): 1176 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ouzzine, L. Antonio, B. Burchell, P. Netter, S. Fournel-Gigleux, and J. Magdalou Importance of Histidine Residues for the Function of the Human Liver UDP-Glucuronosyltransferase UGT1A6: Evidence for the Catalytic Role of Histidine 370 Mol. Pharmacol., April 13, 2001; 58(6): 1609 - 1615. [Abstract] [Full Text] |
||||
![]() |
B. T. Ethell, K. Beaumont, D. J. Rance, and B. Burchell Use of Cloned and Expressed Human UDP-Glucuronosyltransferases for the Assessment of Human Drug Conjugation and Identification of Potential Drug Interactions Drug Metab. Dispos., January 1, 2001; 29(1): 48 - 53. [Abstract] [Full Text] |
||||
![]() |
Q. Ren, S. E. Murphy, Z. Zheng, and P. Lazarus O-Glucuronidation of the Lung Carcinogen 4-(methylnitrosamino)-1- (3-Pyridyl)-1-Butanol (nnal) by Human Udp-Glucuronosyltransferases 2b7 and 1a9 Drug Metab. Dispos., November 1, 2000; 28(11): 1352 - 1360. [Abstract] [Full Text] |
||||
![]() |
T. Shimada, J. Watanabe, K. Kawajiri, T. R. Sutter, F. P. Guengerich, E. M.J. Gillam, and K. Inoue Catalytic properties of polymorphic human cytochrome P450 1B1 variants Carcinogenesis, August 1, 1999; 20(8): 1607 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pless, J. N. Gouze, C. Senay, R. Herber, P. Leroy, V. Barberousse, S. Fournel-Gigleux, and J. Magdalou Characterization of the UDP-Glucuronosyltransferases Involved in the Glucuronidation of An Antithrombotic Thioxyloside in Rat and Humans Drug Metab. Dispos., May 1, 1999; 27(5): 588 - 595. [Abstract] [Full Text] |
||||